🇺🇸 FDA
Patent

US 11034700

Substituted pyrrolidine compound and use thereof

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 11034700 (Substituted pyrrolidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/40, A61K31/4025, A61K31/4035, A61K31/4155